Current Radiopharmaceuticals
Volume 14, 4 Issues, 2021
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Radiopharmaceuticals, Volume 5 - Number 4
Editorial
The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme
, 5(4): 292 - 299Manlio Barbarisi and Pantaleo Romanelli
DOI: 10.2174/1874471011205040292
Advanced Neuroimaging Techniques in the Management of Glioblastoma Multiforme
, 5(4): 300 - 307Claudio Colonnese and Pantaleo Romanelli
DOI: 10.2174/1874471011205040300
Glioblastoma Multiforme Imaging: The Role of Nuclear Medicine
, 5(4): 308 - 313George A. Alexiou, Spyridon Tsiouris, Spyridon Voulgaris, Athanasios P. Kyritsis and Andreas D. Fotopoulos
DOI: 10.2174/1874471011205040308
Synthesis of a Potent Cathepsin S Inhibitor Labeled with Deuterium and Carbon-14
, 5(4): 314 - 317Bachir Latli, Matt Hrapchak, Jon C. Lorenz, Carl A. Busacca and Chris Senanayake
DOI: 10.2174/1874471011205040314
A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab
, 5(4): 318 - 324Victoria Calzada, Xiuli Zhang, Marcelo Fernandez, Arlhee Diaz-Miqueli, Normando Iznaga-Escobar, Susan L. Deutscher, Henia Balter, Thomas P. Quinn and Pablo Cabral
DOI: 10.2174/1874471011205040318
Copper-62 Labeled ReCCMSH Peptide Analogs for Melanoma PET Imaging
, 5(4): 329 - 335Xiuli Zhang, Zhiwei Yue, Bao-Yuan Lu, Gerson J. Vazquez-Flores, Johnny Yuen, Said Daibes Figueroa, Fabio Gallazzi, Cathy Cutler, Thomas P. Quinn and Jeffrey L. Lacy
DOI: 10.2174/1874471011205040329
Polymeric Nanoparticles of FMISO: Are Nano-Radiopharmaceuticals Better Than Conventional Ones?
, 5(4): 336 - 339Marta de Souza Albernaz, Beatriz Ferreira de Carvalho Patricio, Gilberto Weissmuller, Franceline Reynaud, Tom CH Adamsen and Ralph Santos-Oliveira
DOI: 10.2174/1874471011205040336
109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a Potential Agent for Targeted Tumor Therapy
, 5(4): 340 - 347Tapas Das, Sudipta Chakraborty, H. D. Sarma and Sharmila Banerjee
DOI: 10.2174/1874471011205040340
Synthesis of [DTPA-bis(D-ser)] Chelate (DBDSC): An Approach for the Design of SPECT Radiopharmaceuticals Based on Technetium
, 5(4): 348 - 355Raunak Varshney, Swarndeep K. Sethi, Puja P. Hazari, Krishna Chuttani, Sachin Soni, Marilyn D. Milton and Anil K. Mishra
DOI: 10.2174/1874471011205040348
Biodistribution and Pharmacokinetics of I-131 Labelled 4- Iodophenylacetic Acid
, 5(4): 356 - 362Jan Rijn Zeevaart, Zoltan Szucs, Tamsyn Pulker, Thato Sello, Jacqueline Bracher and Mike Sathekge
DOI: 10.2174/1874471011205040356
Editor-in-Chief
Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)
Biography
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Biography
Biography of Sean L. Kitson
Dr Kitson is an Investigator of Radiochemistry at Almac, UK. He has over 15 years of experience in the synthesis of carbon-14 labelled compounds. Dr Kitson is the Editor-in-Chief of Current Radiopharmaceuticals published by Bentham Science Publishers and the Journal of Diagnostic Imaging in Therapy. He has published over 45 research, reviews and commercial articles in the area of carbon-14 synthesis and medical imaging. His contribution to radiochemistry was acknowledged by winning the 2006 Wiley Journal of Labelled Compounds and Radiopharmaceuticals Young Scientists Award. Since, 2007 he has been a Member of the Scientific Committee for the International Isotopes Society (IIS) UK group.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.77
Webmaster Contact: info@benthamscience.net